CN107219310B - The screening method of 110 kinds of drugs in a kind of feed - Google Patents

The screening method of 110 kinds of drugs in a kind of feed Download PDF

Info

Publication number
CN107219310B
CN107219310B CN201710345323.8A CN201710345323A CN107219310B CN 107219310 B CN107219310 B CN 107219310B CN 201710345323 A CN201710345323 A CN 201710345323A CN 107219310 B CN107219310 B CN 107219310B
Authority
CN
China
Prior art keywords
drug
solution
ion
sample
kinds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710345323.8A
Other languages
Chinese (zh)
Other versions
CN107219310A (en
Inventor
吴志明
吴宁鹏
彭丽
张发旺
高延玲
刘占通
陈小鸽
李博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Veterinary Feed Supervision Institute
Original Assignee
Henan Veterinary Feed Supervision Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Veterinary Feed Supervision Institute filed Critical Henan Veterinary Feed Supervision Institute
Priority to CN201710345323.8A priority Critical patent/CN107219310B/en
Publication of CN107219310A publication Critical patent/CN107219310A/en
Application granted granted Critical
Publication of CN107219310B publication Critical patent/CN107219310B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of screening methods of 110 kinds of drugs in feed, specifically includes the following steps: the preparation of standard working solution, the analysis pre-treatment of sample to be tested, foundation and qualitative analysis of database etc., utilize liquid chromatography-tandem quadrupole rod time of-flight mass spectrometer, highly sensitive MSMS function, parent ion and daughter ion in drug can accurately be determined, quickly judge the drug ingedient of addition, establish the detection method of a variety of antibacterials in feed again simultaneously, adding a variety of antibacterials for China's feedstuff industry has efficiently, accurate accurate detection means, belong to domestically leading level at present.The screening method that the present invention establishes, substantially increase disorderly filled out in feedstuff industry disorderly plus the phenomenon that, be the perfect more accurate accurate detection method of detection department, save more times, most experiment consumptive material is saved, the life of food-safe and human health has immeasurable contribution.

Description

The screening method of 110 kinds of drugs in a kind of feed
Technical field
The invention belongs to feed detection technique fields, and in particular to the screening method of 110 kinds of drugs in a kind of feed.
Background technique
It is reported for the first time from Moore etc. (1946), antibacterials is added in feed, the daily gain of broiler chicken can be significantly improved. Successively there are more than 60 Antibiotics usages in animal husbandry since then, in animal diseases control, improves efficiency of feed utilization, promotion livestock and poultry life It is long etc. to have played important function.But it with a large amount of uses of antibacterials, does not abuse scientifically especially, bacterial drug resistance And the problems such as medicament residue, becomes increasingly conspicuous, and causes countries in the world government and the great attention of insider.2006, European Union was comprehensive Prohibit the application of antibacterials feed addictive.China is Production of Livestock and Poultry big country, in China's feed preparation, using anti- The phenomenon that bacterium drug, is very universal.Chemical industry association and pharmaceuticals industry association statistical data in 2005 show that China resists every year Bacterium medicine material output is about 210,000 tons, wherein there is 9.7 ten thousand tons (account for gross annual output amount 46.1%) for animal husbandry.Make It include the Amoxicillin of mono- lactams of B, the gentamicin of aminoglycoside and neomycin, in big ring with the type of antibacterials The erythromycin of esters, woods can amine clindamycin etc..It is reported that 90% in the antibacterials total amount that the whole world consumes every year Be used in edible animal, and wherein 90% be intended only to improve food conversion ratio and as feed addictive come using.
Currently, being mainly using antibacterials problem in feed: 1, blindness, random medication outstanding problem in feed.I State raiser (field) lacks scientific culture technology and animal doctor's knowledge, only with feeling medication;2, excess, long-time service antimicrobial Object;3, occur using when disabling antibacterials phenomenon;Since 2000, country discloses successively some to be prohibited in Production of Livestock and Poultry Drug." veterinary drug and other compound inventories of food animal disabling " announced such as Ministry of Agriculture's in April, 2002.It is wherein bright Text forbids chloramphenicol and its salt, ester (including Chloramphenicol Succinate) and preparation to make the use of all purposes in all food animals.But When in veterinary drug supervision and check or farm and it can be seen that it is more than using still prohibiting.4, people's medicine phenomenon for animals is still deposited ?.It is for animals that " veterinary drug residues regulations " prohibite people's medicine.In production, due to the of less types or people of veterinary drug antibacterials Worry the quality of veterinary drug, often uses medical.5, it is not used by the regulation off-drug period.The length and drug of off-drug period is in animal Intracorporal elimination factor is related with residual quantity, and related with animal species, dosage and administration route.Country is to some veterinary drugs Especially medicated feed additive all defines the off-drug period, but when part raiser (field) uses the feed of drug containing additive Seldom executed by the regulation off-drug period.
Due to the above reasons, to increase the chance of bacterial drug resistance, the body of the mankind is directly or indirectly compromised Health destroys ecological environment.Therefore, quality of the fodder is the basis of human food's safety safely, establishes anti-microbial type in feed Quickly and effectively detection method is very important drug.Existing drug multi-residue determination method mainly has liquid both at home and abroad at present The methods of phase chromatography, liquid chromatography tandem time-of-flight mass spectrometry (TOFMS) and liquid chromatography tandem mass spectrometry.Existing detection method It is comparatively mature to single kind drug research, drug how remaining detection method when establishing factor in need of consideration compared with More, the physical chemical differences of each drug, pre-treating method is complex, and that there are sensitivity is low, medicament categories covering surface is narrow The disadvantages of.Remain the technology special monitoring and early warning advantage that have based on drug, in recent years, each R&D institution, China is also gradually more Pay attention to the research of drug multi-residue determination technology.It is domestic at present to measure in livestock products more left drugs simultaneously and to its accurate quantitative analysis Method more lack, therefore be badly in need of establishing detection technique that is a kind of while measuring a variety of medicament residues.
Summary of the invention
To solve the above problems, the present invention provides a kind of screening method of 110 kinds of drugs in feed, it is residual to be added in feed It stays antibacterials to provide a kind of complete detection method, enriches national industry residue detection standard, increase antibacterials Screening technological means provides safety guarantee for national feed product and green cultivation.
The purpose of the present invention is what is realized with following technical proposals:
The screening method of 110 kinds of drugs in a kind of feed, specifically includes the following steps:
110 kinds of antibacterials are as follows:
(a), macrolides: tylosin, Tilmicosin, Tiamulin, azithromycin, clarithromycin, erythromycin, sieve Erythromycin, Natamycin, oleandomycin, Spiramycin I, kitasamycin;
(b), fluoroquinolones: Enrofloxacin, Ciprofloxacin, sarafloxacin, Difloxacin, Nadifloxacin, Sparfloxacin, Norfloxacin, oxolinic acid, pefloxacin, marbofloxacin, Orbifloxacin, flumequine, acidum nalidixicum, cinoxacin, Lomefloxacin, oxygen Flucloxacillin, fleraxacin;
(c), sulfamido: daimeton, sulfamethoxazole, madribon, sulfaquinoxaline, sulfanilamide (SN) Diformazan pyrimidine, cistosulfa, sulfapryidine, bosporon, ayerlucil, domian, kynix Piperazine, sulfaclozine, fanasil, sulphadiazine, sulfamerazine, bacteresulf, sulfabenzamide, sulfanilamide (SN) nitre Benzene, 5-methoxysulfadiazine, sulphathiazole;
(d), quinoxaline class: quinocetone, carbadox, mequindox, olaquindox;
(e), beta-lactam: ampicillin, oxacillin, flucloxacillin, cefapirin, cefotaxime, cefalexin, Cefradine, Ceftiofur;
(f), woods can amine: lincomycin, clindamycin;
(g), Tetracyclines: terramycin, tetracycline, aureomycin, Doxycycline;
(h), amphenicols: chloramphenicol, Thiamphenicol, Florfenicol;
(i), itrofurans: furazolidone, furaltadone;
(j), nitro glyoxaline: Ornidazole, Dimetridazole, ipronidazole, secnidazole, metronidazole;
(k), anticoccidial class: Robenidine, clopidol;
(l), benzimidazole: febantel, flubendazole, albendazole, Phenbendasol, oxibendazole, oxfendazole, Thiabendazolum, Albendazole sulfone, mebendazol;
(m), beta-receptor agonist: Clenbuterol, Ractopamine, salbutamol, Clorprenaline, Rabat sieve, class's cloth Special sieve, Bbu Tero, bromine Boot sieve;
(n), sedative class: chlorpromazine, droperidol, haloperidol, azaperone, fenazil, Xylazine, Ao Shaxi It dissolves, nitrazepam, diazepam, perphenazine;
(o), antiviral class: amantadine, Rimantadine, famciclovir;
(p), other: trimethoprim, atropine;
(1) preparation of standard working solution:
Each standard items 10mg is accurately weighed, in 10mL measuring bottle, scale is dissolved and is diluted to methanol, is configured to 1mg/mL Each Standard Reserving Solution;For insoluble medicine, a small amount of 0.1mol/LHCl solution is added in Enrofloxacin, Ciprofloxacin, Norfloxacin, A small amount of 0.1mol/L NaOH solution is added in Lomefloxacin, and Cefquinome, olaquindox and quinocetone add appropriate dimethyl sulfoxide to make it It is fixed to scale with methanol after dissolution;
Each Standard Reserving Solution 1mL is measured respectively, and in 100mL measuring bottle, with methanol dilution to scale, being configured to concentration is 10 Working solution among μ g/mL hybrid standard;
Working solution 0.1mL among hybrid standard is taken, is diluted with acetonitrile+water mixed liquid, the work of 1 μ g/mL hybrid standard is made Liquid;
(2) the analysis pre-treatment of sample to be tested:
1) 2 ± 0.02g sample is weighed in 50mL centrifuge tube, addition 6mL extracting solution, vortex 30s, mechanical shaking extraction 10min, It is centrifuged 5min with the speed of 8000r/min, pipettes supernatant in 10mL centrifuge tube;Residue repeats to extract with 4mL acetonitrile, centrifugation After merge supernatant, as reserve liquid;
2) amino solid-phase extraction column is activated with 6mL acetonitrile, is pipetted reserve liquid and is crossed column, and efflux is collected, molten with 50% acetonitrile Liquid is settled to 5mL, mixes, and crosses 0.22 μm of microporous Nylon filter membrane;
(3) Database:
The hybrid standard working solution of 110 kinds of drugs is carried out liquid phase color by the molecular formula and molecular weight for determining 110 kinds of drugs Spectrum-tandem mass spectrum measurement, obtains the total ion current figure of hybrid standard working solution, then the chromatography of ions figure of every kind of drug is extracted Come, determines the retention time of every kind of drug;
The molecular weight of drug and retention time are inputted into MSMS analysis system, MSMS points are carried out to hybrid standard working solution Analysis obtains the daughter ion scanning mass spectrogram of each drug, and according to the fracture mechanism of the fragment of each drug and fracture difficulty, determines each The fragments characteristic ion of drug;
The type of each drug, title, molecular formula, retention time and fragments characteristic ion information are summarized, 110 kinds of medicines are established Object screening database, as shown in the table:
1 database of table
(4) qualitative analysis:
1) liquid chromatography-tandem mass spectrometry analysis is carried out to the sample to be tested by the processing of step (2) the method, will obtained Result be compared with the data in database, blank solvent there can be no quasi-molecular ions identical with standard solution, sample The accurate mass number of parent ion and fragments characteristic ion should be consistent with standard solution, deviation should all≤0.05Da, sample chromatography The retention time at peak, should be consistent with the retention time of standard solution, and allowable deviation is ± 0.2min, parent ion and fragment ion color The signal-to-noise ratio (S/N) of spectral peak is all in 3:1 or more, and signal-to-noise ratio is with peak to peak (PtP) calculating, when full scan spectrum records, in sample The relative abundance of fragments characteristic ion must be over the 10% of the characteristic ion spectrum abundance of standard solution reference, filter out satisfaction The drug of qualitative condition, as doubtful positive sample;
2) for doubtful positive sample, according to the retention time of drug and molecular weight editor's MSMS method, and data are acquired, The daughter ion of obtained doubtful substance scans mass spectrogram, is compared with the daughter ion of standard solution scanning mass spectrogram, in phase Under same condition and similar concentration, the permission of main fragment ion relative abundance and the relative abundance of standard solution is inclined in sample Difference is no more than range as defined in following table, then can determine that as there are corresponding determinands in sample:
The tolerance of the main fragment ion relative abundance of table 2 and the relative abundance of standard solution
Liquid-phase chromatographic analysis condition in the step (3) and step (4) are as follows: use Waters UPLCTMBEH C18 color Column is composed, 2.1mm × 100mm, 1.7 μm, organic Phase Proportion is slowly varying to 95% from initial 2%, to guarantee all drugs all It can effectively detect, gradient elution program see the table below 3:
3 chromatography gradient elution program of table
Note: ESI+:A:0.1% formic acid solution;B: acetonitrile, gradient elution;
ESI-:A: water;B: acetonitrile, gradient elution;
1 is variation immediately, and 6 be linear change.
Mass spectral analysis condition in the step (3) and step (4) is as shown in the table:
4 source parameters of table
5 screening mass spectrometry method parameter of table
Note: leucine enkephalin real-time online molecular weight calibration, molecular weight are 556.2771 (ESI+)/554.2615 (ESI-), sweep time 0.5s, sweep spacing 10s.
The volume ratio of the acetonitrile of the mixed liquor of acetonitrile and water and water is 1:1 in the step (1).
Extracting solution in the step (2) is the mixed solution of acetonitrile and water, and the volume ratio of acetonitrile and water is 1:1.
Further include the measurement of the detection limit to 110 kinds of drugs, measuring method are as follows: addition 10 μ g/mL standard solution, 100 μ L in In 2g blank feed, measured after extracted, the signal-to-noise ratio S/N > 3 of drug shows that the detection of each drug is limited to 0.5mg/kg.
The present invention utilizes liquid chromatography-tandem quadrupole rod time of-flight mass spectrometer, highly sensitive MSMS function, Neng Goujing True determines parent ion and daughter ion in drug, quickly judges the drug ingedient of addition.This method has wide range of applications, The detection method for establishing a variety of antibacterials in feed again simultaneously, adding a variety of antibacterials for China's feedstuff industry has Efficiently, accurate accurate detection means, belongs to domestically leading level at present.The screening method that the present invention establishes, substantially increases Disorderly filled out in feedstuff industry disorderly plus the phenomenon that, be the perfect more accurate accurate detection method of detection department, when saving more Between, most experiment consumptive material is saved, the life of food-safe and human health has immeasurable contribution.
Detailed description of the invention
Fig. 1 is the total ion current figure (ESI+) of mixed standard solution.
Fig. 2 is the extraction chromatography of ions figure (ESI+) of Enrofloxacin.
Fig. 3 is Enrofloxacin standard solution daughter ion scanning mass spectrogram.
Fig. 4 is lincomycin standard solution fragments characteristic the ion extraction chromatogram.
Fig. 5 is lincomycin standard solution parent ion extraction chromatography figure.
Fig. 6 is lincomycin fragments characteristic the ion extraction chromatogram in sample 1.
Fig. 7 is lincomycin parent ion extraction chromatography figure in sample 1.
Fig. 8 is lincomycin standard solution secondary fragment ions mass spectrogram.
Fig. 9 is lincomycin secondary fragment ions mass spectrogram in sample 1.
Figure 10 is albendazole standard solution fragments characteristic the ion extraction chromatogram
Figure 11 is albendazole standard solution parent ion extraction chromatography figure.
Figure 12 is albendazole fragments characteristic the ion extraction chromatogram in sample 5.
Figure 13 is albendazole parent ion extraction chromatography figure in sample 5.
Figure 14 is albendazole standard solution secondary fragment ions mass spectrogram.
Figure 15 is albendazole secondary fragment ions mass spectrogram in sample 5.
Figure 16 is the schematic diagram for the thinking that two or more complementary solid-phase extraction columns are used cooperatively.
Figure 17 is Carb and NH2With the use of when flow diagram.
Specific embodiment
The feed is mixed feed, concentrated feed, premixed feed.
110 kinds of antibacterials are as follows:
(a), macrolides (11 kinds): tylosin, Tilmicosin, Tiamulin, azithromycin, clarithromycin, red Mycin, roxithromycin, Natamycin, oleandomycin, Spiramycin I, kitasamycin;
(b), fluoroquinolones (17 kinds): Enrofloxacin, Ciprofloxacin, sarafloxacin, Difloxacin, Nadifloxacin, department Pa sand star, Norfloxacin, oxolinic acid, pefloxacin, marbofloxacin, Orbifloxacin, flumequine, acidum nalidixicum, cinoxacin, Lome Sha Xing, Ofloxacin, fleraxacin;
(c), sulfamido (20 kinds): daimeton, sulfamethoxazole, madribon, sulfanilamide (SN) quinoline are disliked Quinoline, sulfadimidine, cistosulfa, sulfapryidine, bosporon, ayerlucil, domian, sulphur Amine methoxy piperazine, sulfaclozine, fanasil, sulphadiazine, sulfamerazine, bacteresulf, sulfabenzamide, Sulfanitran, 5-methoxysulfadiazine, sulphathiazole;
(d), quinoxaline class (4 kinds): quinocetone, carbadox, mequindox, olaquindox;
(e), beta-lactam (8 kinds): ampicillin, oxacillin, flucloxacillin, cefapirin, cefotaxime, cephalo Ammonia benzyl, Cefradine, Ceftiofur;
(f), woods can amine (2 kinds): lincomycin, clindamycin;
(g), Tetracyclines (4 kinds): terramycin, tetracycline, aureomycin, Doxycycline;
(h), amphenicols (3 kinds): chloramphenicol, Thiamphenicol, Florfenicol;
(i), itrofurans (2 kinds): furazolidone, furaltadone;
(j), nitro glyoxaline (5 kinds): Ornidazole, Dimetridazole, ipronidazole, secnidazole, metronidazole;
(k), anticoccidial class (2 kinds): Robenidine, clopidol;
(l), benzimidazole (9 kinds): febantel, flubendazole, albendazole, Phenbendasol, oxibendazole, Ao Fen It rattles away azoles, thiabendazolum, Albendazole sulfone, mebendazol;
(m), beta-receptor agonist (8 kinds): Clenbuterol, Ractopamine, salbutamol, Clorprenaline, Rabat sieve, Bambuterol, Bbu Tero, bromine Boot sieve;
(n), sedative class (10 kinds): chlorpromazine, droperidol, haloperidol, azaperone, fenazil, Xylazine, Austria Sha Xi dissolves, nitrazepam, diazepam, perphenazine;
(o), antiviral class (3 kinds): amantadine, Rimantadine, famciclovir;
(p), other (2 kinds): trimethoprim, atropine.
1. the preparation of standard working solution:
Each standard items 10mg is accurately weighed, in 10mL measuring bottle, scale is dissolved and is diluted to methanol, is configured to 1mg/mL Each Standard Reserving Solution;For insoluble medicine, a small amount of 0.1mol/LHCl solution is added in Enrofloxacin, Ciprofloxacin, Norfloxacin, A small amount of 0.1mol/L NaOH solution is added in Lomefloxacin, and Cefquinome, olaquindox and quinocetone add appropriate dimethyl sulfoxide to make it It is fixed to scale with methanol after dissolution;
Each Standard Reserving Solution 1mL is measured respectively, and in 100mL measuring bottle, with methanol dilution to scale, being configured to concentration is 10 Working solution among μ g/mL hybrid standard;
Working solution 0.1mL among hybrid standard is taken, is diluted with acetonitrile+water mixed liquid, the work of 1 μ g/mL hybrid standard is made Liquid.
2. the analysis pre-treatment of sample to be tested:
2.1 take smashed test sample, as sample of having a try.
The storage of 2.2 air dryings is spare.
The screening of 2.3 extracting solutions and sample extraction
2.3.1 the selection of Extraction solvent
With reference to pertinent literature, we have investigated these three more common solution of acetonitrile, first alcohol and water.It has been respectively compared acetonitrile And the effect that methanol different proportion aqueous solution extracts, find acetonitrile+water and methanol+water as extracting solution, the extraction of drug Effect is all more satisfactory.But methanol+water sedimentation effect is poor, the muddy difficult purification of extracting solution, so selecting extraction efficiency height simultaneously And the good acetonitrile+water of sedimentation effect is as extracting solution.After the rate of recovery for comparing different proportion acetonitrile water, 6mL is finally used Water+acetonitrile (50+50, v/v) extracts, and residue repeats to extract with 4mL acetonitrile.
2.3.2 2g sample (being accurate to 0.01g) is weighed in 50mL centrifuge tube, and 6mL water+acetonitrile (50+50, v/v) is added, Vortex 30s, mechanical shaking extraction 10min are centrifuged 5min with the speed of 8000r/min, pipette supernatant in 10mL centrifuge tube.Residue Repeat to extract primary, centrifugation, merging supernatant, as reserve liquid with 4mL acetonitrile.
2.3.3 the determination of purification condition
According to experimental conditions, we devise following several purification schemes:
1) extracting solution direct purification grease removal
a.NH2Column: acetonitrile activation → loading → collected column liquid → nitrogen and blows → constant volume.
B. carbon black column: methylene chloride, methanol activation → loading → collected column liquid → nitrogen and blow → constant volume.
C. alumina column (acid, neutral, alkalinity): acetonitrile activation → loading → collected column liquid → nitrogen and blows → constant volume.
D. n-hexane grease removal.
2) extracting solution is dried with nitrogen, and Solid Phase Extraction column purification is crossed after being dissolved in water, and eluent is dried with nitrogen rear constant volume mistake Machine in filter investigates purification and retention.The common solids extraction column such as MAX, MCX, HLB, SCX, carbon black is mainly investigated.Processing Method is as follows:
A.MAX: methanol, water activation → loading → water, methanol elute the elution of → 5% formic acid methanol.
B.MCX, SCX: methanol, water activation → loading → water, methanol elute the elution of → 5% ammoniated methanol.
C.HLB: methanol, water activation → loading → water elution → methanol elution.
D.Carb: methylene chloride, methanol, water activation → loading → methanol elution.
3) since these extraction columns selectivity is stronger, and the nature difference of drug is very big, and a kind of pillar can not be to all Drug is withed a hook at the end, therefore it is contemplated that two or more complementary solid-phase extraction columns is used cooperatively, thinking such as 16 institute of attached drawing Show.
For example, Carb and NH2With the use of when flow chart it is as shown in Fig. 17.
Investigated the methods of n-hexane grease removal and Solid Phase Extraction column purification respectively, due to n-hexane and acetonitrile have it is certain mutual Dissolubility, therefore acetonitrile saturation n-hexane is used to carry out grease removal, the discovery rate of recovery is lower, and reason may be interference component removal in matrix Not exclusively, still detection is interfered, or is that a part of object dissolves in n-hexane layer during grease removal, caused certain Loss.Investigated SCX column, MCX column, MAX column and HLB column pair, since various kinds of drug active group is different, retention difference compared with Greatly, the macrolides rate of recovery is not retained between 64%~92%, but to sulfa drugs such as SCX column.It examines respectively Nh 2 column, aluminium oxide (neutral, alkalinity and acidity) column and carbon black column have been examined to the rate of recovery of each drug.The result shows that aluminium oxide Pillar is extremely low to tetracycline and the quinolone drugs rate of recovery, and carbon black column is poor to quinolone drugs yield, and nh 2 column pair Protein has certain reservation, has achieved the purpose that purification, while all drugs have preferable recycling, can satisfy experiment It is required that.
It is final to determine purification method are as follows: amino solid-phase extraction column is activated with 6mL acetonitrile, is pipetted reserve liquid and is crossed column, collects stream Liquid out is settled to 5mL with 50% acetonitrile solution, mixes, and crosses 0.22 μm of microporous Nylon filter membrane.
3. instrument parameter is set
3.1 liquid chromatogram reference conditions
Chromatographic column: Waters UPLCTM BEH C18Column, column length 100mm, column internal diameter 2.1mm, 1.7 μm or comparable of granularity Analytical column.
Column temperature: 40 DEG C.
Mobile phase:
ESI+:A phase: 0.1% formic acid solution, B phase: acetonitrile, gradient elution.
ESI-:A phase: water;B phase: acetonitrile, gradient elution.
Gradient elution program is shown in Table 3-1.
Flow velocity: 0.45mL/min.
Sample volume: 2 μ L.
Table 3-1 chromatography gradient elution program
Note: 1 is variation immediately, and 6 be linear change.
3.2 mass spectral analysis conditions
Since the medicament categories being related to are more, and pharmaceutical properties difference is big, it is impossible to which every kind of drug all reaches optimum detection item Part.It is final to determine source parameters screening mass spectrometry method parameter after optimization, respectively as shown in table 3-2, table 3-3, at this Under part, most of drug has preferable response.
Table 3-2 source parameters
Table 3-3 flight time mass spectrum method parameter
Note: leucine enkephalin real-time online molecular weight calibration, molecular weight are 556.2771 (ESI+)/554.2615 (ESI-), sweep time 0.5s, sweep spacing 10s.
4. the foundation of database:
The hybrid standard working solution of each drug is carried out liquid phase color by the molecular formula and accurate molecular weight for determining 110 kinds of drugs Spectrum-tandem mass spectrum measurement, obtains the total ion current figure of hybrid standard working solution, as shown in Figure 1;Again the ion color of every kind of drug Spectrogram extracts, and determines the retention time of every kind of drug, and by taking Enrofloxacin as an example, it is as shown in Figure 2 to extract result;
The molecular weight of drug and retention time are inputted into MSMS analysis system, MSMS points are carried out to hybrid standard working solution Analysis obtains the daughter ion scanning mass spectrogram of each drug, and by taking Enrofloxacin as an example, the daughter ion scanning mass spectrogram of Enrofloxacin is as schemed Shown in 3, and according to the fracture mechanism of the fragment of each drug and fracture difficulty, the fragments characteristic ion of each drug is determined;
The type of each drug, title, molecular formula, retention time and fragments characteristic ion information are summarized, established non-in 122 Prescription drug screening database, as shown in the table:
Table 4-1 database
5. the sample to be tested progress liquid chromatography-tandem mass spectrometry analysis measurement pair handled by step 2 the method, sample introduction Sequentially are as follows:
Solvent blank is into 1 needle;
Whether standard working solution determines system within allowable error into 1 needle, RSD < 10%;
Solvent blank is into 1 needle;
Sample 1 is into 1 needle;
Solvent blank is into 1 needle;
…………
Alternately;
…………
Reagent blank is into 1 needle;
Standard working solution is into 1 needle;
…………
Note: any adjustment of sequence should have adequate cause to prove its reasonability.
6. qualitative analysis and result confirmation
6.1 qualitative analysis
The result that step 5 obtains is compared with the data in database, blank solvent there can be no with standard solution Identical quasi-molecular ions, the parent ion of sample and the accurate mass number of fragments characteristic ion should be consistent with standard solution, and deviation is equal Answer≤0.05Da, the retention time of sample chromatographic peak should be consistent with the retention time of standard solution, allowable deviation be ± The signal-to-noise ratio (S/N) of 0.2min, parent ion and fragment ion chromatographic peak is all in 3:1 or more, and signal-to-noise ratio is in terms of peak to peak (PtP) Calculate, when full scan spectrum records, in sample the relative abundance of fragments characteristic ion must be over the feature of standard solution reference from Sub-light composes the 10% of abundance, filters out the drug for meeting qualitative condition, as doubtful positive sample.
6.2 results confirmation
For doubtful positive sample, according to the retention time of drug and molecular weight editor's MS/MS method, and data are acquired, The daughter ion of obtained doubtful substance scans mass spectrogram, is compared with the daughter ion of standard solution scanning mass spectrogram, in phase Under same condition and similar concentration, the permission of main fragment ion relative abundance and the relative abundance of standard solution is inclined in sample Difference is no more than range as defined in following table, then can determine that as there are corresponding determinands in sample:
The tolerance of the main fragment ion relative abundance of table 6-1 and the relative abundance of standard solution
Relative ion abundance (%) >50 > 20~50 > 10~20 ≤10
The maximum deviation (%) of permission ±20 ±25 ±30 ±50
7. actual sample detects
Sample to be tested is detected in aforementioned manners, as a result as shown in table 7-1, positive findings are shown in Fig. 4-15.
Table 7-1 actual sample testing result
Sample number into spectrum Feed title Sample source Detect over the counter ingredient
1 Chicken batch Farm Lincomycin
2 Chicken concentrate feed Feed Enterprise It is not detected
3 Pig premix Farm It is not detected
4 Pig concentrate feed Farm It is not detected
5 Pig batch Feed Enterprise Albendazole
8. detecting the determination of limit
In order not to cause the pollution of instrument, on sample before machine measurement, measured after at least diluting 1000 times to sample.By After injection, solution and the extracted liquid dilution of soluble powder, the solution of upper machine measurement and the solution of standard items are substantially equivalent.Cause This, we limit the detection that the detection of various drug standards is limited to this method.Add 10 μ g/mL standard solution, 100 μ L in In 2g blank feed, measured after extracted, the signal-to-noise ratio S/N > 3 of drug shows that the detection of each drug is limited to 0.5mg/kg.
9. the rate of recovery is tested
It selects blank mixed feed, concentrated feed and premixed feed sample as test object, carries out mark-on test.? 0.5mg/kg concentration carries out recovery of standard addition experiment, and 3 parallel laboratory tests calculate relative standard deviation.110 kinds of the average of drug return Yield and relative standard deviation are shown in Table 9-1.
Table 9-1 TIANZHU XINGNAO Capsul test result
What has been described above is only a preferred embodiment of the present invention, it is noted that for those skilled in the art, Without depart from that overall concept of the invention, several changes and improvements can also be made, these also should be considered as of the invention Protection scope.

Claims (4)

1. the screening method of 110 kinds of drugs in a kind of feed, it is characterised in that: specifically includes the following steps:
110 kinds of antibacterials are as follows:
(a), macrolides: tylosin, Tilmicosin, Tiamulin, azithromycin, clarithromycin, erythromycin, Luo Hong are mould Element, Natamycin, oleandomycin, Spiramycin I, kitasamycin;
(b), fluoroquinolones: Enrofloxacin, Ciprofloxacin, sarafloxacin, Difloxacin, Nadifloxacin, Sparfloxacin, promise fluorine Sha Xing, oxolinic acid, pefloxacin, marbofloxacin, Orbifloxacin, flumequine, acidum nalidixicum, cinoxacin, Lomefloxacin, oxygen fluorine are husky Star, fleraxacin;
(c), sulfamido: daimeton, sulfamethoxazole, madribon, sulfaquinoxaline, sulfanilamide (SN) diformazan Pyrimidine, cistosulfa, sulfapryidine, bosporon, ayerlucil, domian, kynix, sulphur Amine chloropyrazine, fanasil, sulphadiazine, sulfamerazine, bacteresulf, sulfabenzamide, sulfanitran, sulphur Amine is to Sulfamonomethoxine, sulphathiazole;
(d), quinoxaline class: quinocetone, carbadox, mequindox, olaquindox;
(e), beta-lactam: ampicillin, oxacillin, flucloxacillin, cefapirin, cefotaxime, cefalexin, cephalo Draw fixed, Ceftiofur;
(f), woods can amine: lincomycin, clindamycin;
(g), Tetracyclines: terramycin, tetracycline, aureomycin, Doxycycline;
(h), amphenicols: chloramphenicol, Thiamphenicol, Florfenicol;
(i), itrofurans: furazolidone, furaltadone;
(j), nitro glyoxaline: Ornidazole, Dimetridazole, ipronidazole, secnidazole, metronidazole;
(k), anticoccidial class: Robenidine, clopidol;
(l), benzimidazole: febantel, flubendazole, albendazole, Phenbendasol, oxibendazole, oxfendazole, thiophene benzene Up to azoles, Albendazole sulfone, mebendazol;
(m), beta-receptor agonist: Clenbuterol, Ractopamine, salbutamol, Clorprenaline, Rabat sieve, bambuterol, Bbu Tero, bromine Boot sieve;
(n), sedative class: chlorpromazine, droperidol, haloperidol, azaperone, fenazil, Xylazine, Oxazepam, nitre West dissolves, diazepam, perphenazine;
(o), antiviral class: amantadine, Rimantadine, famciclovir;
(p), other: trimethoprim, atropine;
(1) preparation of standard working solution:
Each standard items 10mg is accurately weighed, in 10mL measuring bottle, scale is dissolved and be diluted to methanol, 1mg/mL is configured to and respectively marks Quasi- stock solution;For insoluble medicine, a small amount of 0.1mol/L HCl solution, Lome is added in Enrofloxacin, Ciprofloxacin, Norfloxacin A small amount of 0.1mol/L NaOH solution is added in Sha Xing, and Cefquinome, olaquindox and quinocetone add appropriate dimethyl sulfoxide to make it dissolve Afterwards, fixed to scale with methanol;
Each Standard Reserving Solution 1mL is measured respectively, and in 100mL measuring bottle, with methanol dilution to scale, being configured to concentration is 10 μ g/ Working solution among mL hybrid standard;
Working solution 0.1mL among hybrid standard is taken, is diluted with acetonitrile+water mixed liquid, 1 μ g/mL hybrid standard working solution is made;
(2) the analysis pre-treatment of sample to be tested:
1) 2 ± 0.02g sample is weighed in 50mL centrifuge tube, addition 6mL extracting solution, vortex 30s, mechanical shaking extraction 10min, with The speed of 8000r/min is centrifuged 5min, pipettes supernatant in 10mL centrifuge tube;Residue repeats to extract with 4mL acetonitrile, after centrifugation Merge supernatant, as reserve liquid;
2) amino solid-phase extraction column is activated with 6mL acetonitrile, is pipetted reserve liquid and is crossed column, collects efflux, fixed with 50% acetonitrile solution Hold to 5mL, mix, crosses 0.22 μm of microporous Nylon filter membrane;
(3) Database:
The hybrid standard working solution of 110 kinds of drugs is carried out liquid chromatogram-string by the molecular formula and molecular weight for determining 110 kinds of drugs Join mass spectroscopy, obtains the total ion current figure of hybrid standard working solution, then the chromatography of ions figure of every kind of drug is extracted, really The retention time of fixed every kind of drug;
The molecular weight of drug and retention time are inputted into MSMS analysis system, MSMS analysis is carried out to hybrid standard working solution, is obtained Daughter ion to each drug scans mass spectrogram, and according to the fracture mechanism of the fragment of each drug and fracture difficulty, determines each drug Fragments characteristic ion;
The type of each drug, title, molecular formula, retention time and fragments characteristic ion information are summarized, 110 kinds of drug sieves are established Database is looked into, as shown in the table:
1 database of table
(4) qualitative analysis:
1) liquid chromatography-tandem mass spectrometry analysis, the knot that will be obtained are carried out to the sample to be tested by the processing of step (2) the method Fruit is compared with the data in database, blank solvent there can be no quasi-molecular ions identical with standard solution, sample it is female from Son and the accurate mass number of fragments characteristic ion should be consistent with standard solution, deviation should all≤0.05Da, sample chromatographic peak Retention time, should be consistent with the retention time of standard solution, and allowable deviation is ± 0.2min, parent ion and fragment ion chromatographic peak Signal-to-noise ratio (S/N) all in 3:1 or more, signal-to-noise ratio is with peak to peak (PtP) calculating, when full scan spectrum records, feature in sample The relative abundance of fragment ion must be over the 10% of the characteristic ion spectrum abundance of standard solution reference, filter out meet it is qualitative The drug of condition, as doubtful positive sample;
2) for doubtful positive sample, according to the retention time of drug and molecular weight editor's MSMS method, and data are acquired, gained The daughter ion of the doubtful substance arrived scans mass spectrogram, is compared with the daughter ion of standard solution scanning mass spectrogram, identical The tolerance of main fragment ion relative abundance and the relative abundance of standard solution is not under condition and similar concentration, in sample More than range as defined in following table, then can determine that as there are corresponding determinands in sample:
The tolerance of the main fragment ion relative abundance of table 2 and the relative abundance of standard solution
Relative ion abundance (%) >50 > 20~50 > 10~20 ≤10 The maximum deviation (%) of permission ±20 ±25 ±30 ±50
Liquid-phase chromatographic analysis condition in the step (3) and step (4) are as follows: use Waters UPLCTMBEH C18 chromatography Column, 2.1mm × 100mm, 1.7 μm, organic Phase Proportion is slowly varying to 95% from initial 2%, to guarantee that all drugs can Effectively detection, gradient elution program see the table below 3:
3 chromatography gradient elution program of table
Note: ESI+:A:0.1% formic acid solution;B: acetonitrile, gradient elution;
ESI-:A: water;B: acetonitrile, gradient elution;
1 is variation immediately, and 6 be linear change;
Mass spectral analysis condition in the step (3) and step (4) is as shown in the table:
4 source parameters of table
5 screening mass spectrometry method parameter of table
Note: leucine enkephalin real-time online molecular weight calibration, molecular weight are 556.2771 (ESI+)/554.2615 (ESI-), Sweep time 0.5s, sweep spacing 10s.
2. the screening method of 110 kinds of drugs in feed according to claim 1, it is characterised in that: second in the step (1) The volume ratio of acetonitrile and water in the mixed liquor of nitrile and water is 1:1.
3. the screening method of 110 kinds of drugs in feed according to claim 1, it is characterised in that: in the step (2) Extracting solution is the mixed solution of acetonitrile and water, and the volume ratio of acetonitrile and water is 1:1.
4. the screening method of 110 kinds of drugs in feed according to claim 1, it is characterised in that: further include to 110 kinds of medicines The measurement of the detection limit of object, measuring method are as follows: 10 μ g/mL standard solution, 100 μ L is in 2g blank feed for addition, surveys after extracted Fixed, the signal-to-noise ratio S/N > 3 of drug shows that the detection of each drug is limited to 0.5mg/kg.
CN201710345323.8A 2017-05-16 2017-05-16 The screening method of 110 kinds of drugs in a kind of feed Active CN107219310B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710345323.8A CN107219310B (en) 2017-05-16 2017-05-16 The screening method of 110 kinds of drugs in a kind of feed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710345323.8A CN107219310B (en) 2017-05-16 2017-05-16 The screening method of 110 kinds of drugs in a kind of feed

Publications (2)

Publication Number Publication Date
CN107219310A CN107219310A (en) 2017-09-29
CN107219310B true CN107219310B (en) 2019-06-07

Family

ID=59944152

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710345323.8A Active CN107219310B (en) 2017-05-16 2017-05-16 The screening method of 110 kinds of drugs in a kind of feed

Country Status (1)

Country Link
CN (1) CN107219310B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107727769B (en) * 2017-10-24 2020-11-27 蒋万枫 Method for rapidly screening and confirming veterinary drug residues in milk
CN108072714B (en) * 2017-12-06 2021-01-19 武汉生物工程学院 Method for detecting content of chloramphenicol in animal feed by combining thin-layer chromatography with high performance liquid chromatography
CN108195963B (en) * 2017-12-29 2021-03-05 宁夏希望田野生物农业科技有限公司 Method for detecting residual quantity of erythromycin in soil
CN108445135A (en) * 2018-05-23 2018-08-24 南京财经大学 A kind of detection method for a variety of residue of veterinary drug rapid screenings
CN108982715A (en) * 2018-06-26 2018-12-11 辽宁禾丰牧业股份有限公司 The detection method of antibiotics in a kind of feed
CN109212061A (en) * 2018-09-03 2019-01-15 江西省农业科学院农产品质量安全与标准研究所 The detection method of Determination of norfloxacin residue amount in a kind of animal hair
CN109557206B (en) * 2018-12-03 2021-08-10 农业农村部环境保护科研监测所 Method for simultaneously and accurately detecting 45 antibiotics in livestock and poultry manure
CN109342624A (en) * 2018-12-07 2019-02-15 上海市环境科学研究院 The method that Solid Phase Extraction pre-treatment combination LC-MS technology detects 15 kinds of antibiotic in aquaculture system simultaneously
CN109298109A (en) * 2018-12-07 2019-02-01 昌邑市检验检测中心 In meat product a variety of beasts it is residual and meanwhile detection method
CN109765306A (en) * 2018-12-20 2019-05-17 山东省海洋资源与环境研究院 The detection method of diazepam in a kind of fresh water
CN109709227B (en) * 2018-12-30 2021-09-24 中国水产科学研究院长江水产研究所 Method for measuring residual quantity of robenidine hydrochloride and metabolites thereof in aquatic product by high performance liquid chromatography-tandem mass spectrometry
CN111458417B (en) * 2019-01-21 2023-03-24 深圳华大生命科学研究院 Method and kit for combined detection of multiple antibiotics in sample to be detected
CN109557216B (en) * 2019-01-22 2020-02-18 中国农业科学院农业质量标准与检测技术研究所 Identification method of filter residue mixed with tylosin in rapeseed dregs
CN110412147A (en) * 2019-06-12 2019-11-05 温氏食品集团股份有限公司 A kind of ceftiofur sodium is in the intracorporal pharmacokinetics of chicken and eliminates detection method
CN111060638B (en) * 2019-08-31 2022-06-03 河南省兽药饲料监察所(河南省畜产品质量监测检验中心) Screening and confirming method for 207 veterinary drugs and additives in animal food
CN110632196A (en) * 2019-09-21 2019-12-31 王成梅 Method for simultaneously and quantitatively determining olaquindox, mequindox and carbalkoxy in feed
CN111650298A (en) * 2020-06-09 2020-09-11 武汉市农业科学院 Method for simultaneously detecting 5 sulfonamides in cow dung by solid-phase extraction-high performance liquid chromatography
CN112362797B (en) * 2020-10-26 2022-05-27 浙江国正检测技术有限公司 Method for detecting quinolone drugs in feed
CN113484433B (en) * 2021-06-30 2023-04-21 贵州大学 Method for measuring content of six anticoccidial drugs in feed by liquid chromatography
CN113376292B (en) * 2021-07-09 2023-01-03 广东省药品检验所(广东省药品质量研究所、广东省口岸药品检验所) Method for simultaneously determining residues of 3 veterinary drugs in honeyed pills or water-honeyed pills
CN115201373B (en) * 2022-07-13 2023-07-28 北京英太格瑞检测技术有限公司 Method for detecting LC-MSMS (LC-MSMS) in feed without using ion pair reagent in mobile phase

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101363818A (en) * 2008-05-16 2009-02-11 天津生机集团股份有限公司 Method for rapidly detecting Contraband Medicine in feedstuff or veterinary drugs
JP2011163827A (en) * 2010-02-05 2011-08-25 Kagoshima Univ METHOD FOR EXTRACTING GROWTH ACCELERATION SUBSTANCE AND alpha-TOCOPHEROL USING SHOCHU LEES
JP2013253790A (en) * 2012-06-05 2013-12-19 Chube Univ Analytical method of nivalenol
CN104792899A (en) * 2015-04-27 2015-07-22 山东省分析测试中心 Method for detecting residue of multiple quinolones in feed by adopting HPLC-ESI-MS/MS process
CN105527366A (en) * 2015-12-01 2016-04-27 赵林萍 Detection method for antibiotic residues in feeds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101363818A (en) * 2008-05-16 2009-02-11 天津生机集团股份有限公司 Method for rapidly detecting Contraband Medicine in feedstuff or veterinary drugs
JP2011163827A (en) * 2010-02-05 2011-08-25 Kagoshima Univ METHOD FOR EXTRACTING GROWTH ACCELERATION SUBSTANCE AND alpha-TOCOPHEROL USING SHOCHU LEES
JP2013253790A (en) * 2012-06-05 2013-12-19 Chube Univ Analytical method of nivalenol
CN104792899A (en) * 2015-04-27 2015-07-22 山东省分析测试中心 Method for detecting residue of multiple quinolones in feed by adopting HPLC-ESI-MS/MS process
CN105527366A (en) * 2015-12-01 2016-04-27 赵林萍 Detection method for antibiotic residues in feeds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Development and Validation of a Liquid Chromatographic/Tandem Mass Spectrometric Method for Determination of Chlortetracycline, Oxytetracycline, Tetracycline, and Doxycycline in Animal Feeds;Guo, Liang; Chen, Yiqiang; Zhang, Liying;《JOURNAL OF AOAC INTERNATIONAL》;20120831;第95卷(第4期);1010-1015
Method for determination of streptomycin and streptidine as markers for streptomycin industrial dregs monitoring in pig and poultry compound feeds;Li, Yang; Su, Xiaoou; Peng, Qing;《JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES》;20160926;第1035卷;84-90
超高效液相色谱-串联质谱法测定饲料中6大类50种药物;赵健;《分析试验室》;20140630;第33卷(第6期);713-718
超高效液相色谱-静电场轨道离子阱高分辨质谱联用筛查分析饲料中抗菌类药物;王国庆;《轻工学报》;20160731;第31卷(第4期);15-22

Also Published As

Publication number Publication date
CN107219310A (en) 2017-09-29

Similar Documents

Publication Publication Date Title
CN107219310B (en) The screening method of 110 kinds of drugs in a kind of feed
CN107202839B (en) The screening method of 108 kinds of non-prescription drugs in a kind of veterinary drug preparation
US20210063375A1 (en) Screening and confirmation method for veterinary drugs and additives in animal-derived food
Li et al. Multiclass analysis of 25 veterinary drugs in milk by ultra-high performance liquid chromatography-tandem mass spectrometry
CN103884790B (en) Method for determining multiresidue of veterinary drugs in animal-derived foods
Wang et al. Multi-class analysis of veterinary drugs in eggs using dispersive-solid phase extraction and ultra-high performance liquid chromatography-tandem mass spectrometry
Jank et al. Liquid chromatography–tandem mass spectrometry multiclass method for 46 antibiotics residues in milk and meat: development and validation
CN102175784B (en) Method for synchronously detecting 54 medicament residues in pork by virtue of solid phase extraction-liquid chromatogram-mass spectrum/mass spectrometry
CN107490649A (en) The screening method of 62 kinds of antibacterials in a kind of farm animal excrement
CN109633065B (en) Method for detecting drug residues in animal body
CN104764844A (en) Detection method of measuring residue amount of 35 veterinary drugs in meat of poultry and livestock
Robert et al. Rapid multiresidue and multi-class screening for antibiotics and benzimidazoles in feed by ultra high performance liquid chromatography coupled to tandem mass spectrometry
CN109085263A (en) Liquid chromatography tandem mass spectrometry detects the kit of anti-schizophrenia drug and its application in serum plasma
CN107576744A (en) A kind of method for detecting animal derived food veterinary drug residue
CN109557206A (en) A kind of method that 45 kinds of antibiotic precisely detect simultaneously in feces of livestock and poultry
CN101963602A (en) Column switching LC-MS/MS analysis method for detecting soporific and sedative drugs and metabolins thereof in urine
CN107290470B (en) A kind of method of sulfamido and quinolones medicament relict in quick measurement egg
CN108132319A (en) Liquid Chromatography-Tandem Mass Spectrometry that is a kind of while measuring 10 94 kinds of left drugs of class in livestock and poultry
CN106896172A (en) Method for quick being remained a kind of animal derived food herbal medicine more
Kaklamanos et al. Multi-residue method for the detection of veterinary drugs in distillers grains by liquid chromatography–Orbitrap high resolution mass spectrometry
CN101571526A (en) Detection method for simultaneously measuring residue of nitroimidazoles drugs in royal jelly
Spisso et al. A liquid chromatography–tandem mass spectrometry confirmatory assay for the simultaneous determination of several tetracyclines in milk considering keto–enol tautomerism and epimerization phenomena
CN107991407A (en) Method that is a kind of while detecting 35 kinds of residues of veterinary drug in meat products
CN111812218A (en) Method for simultaneously detecting concentration of multiple antipsychotic drugs in serum
Roach et al. Evaluation and single laboratory validation of an on-line turbulent flow extraction tandem mass spectrometry method for melamine in infant formula

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant